Clinical Trial Update: Maine Implementation Study - Phase III [NA]

View source ↗

Summary

Harvard University's Phase III Maine Implementation Study has completed. It examines anxiety, trauma-related disorders, depression, and related behavioral issue…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Depressive Disorders
• Post-traumatic Stress Disorder

Snippet

Sponsor: Harvard University | Conditions: Anxiety, Trauma | NA | Status: COMPLETED